Phase 1b study of tarlatamab in de novo or treatment-emergent neuroendocrine prostate cancer (NEPC).

Aggarwal, Rahul Raj, Rottey, Sylvie, Bernard-Tessier, Alice · Journal of Clinical Oncology · 2024